Mesosil is a materials science company making responsive additives for dental materials to prevent infection and cavities, the most common medical conditions in the world. Mesosil has developed the first lifetime-effect line of antimicrobial materials to prevent the long-term breakdown, infection, and recurrent disease responsible for up to 70% of treatment failures in dentistry. These improvements will allow for truly permanent solutions that no longer leave teeth and gums vulnerable to bacterial attack. Mesosil’s technology outclasses competitors in two key areas: biostability and antimicrobial efficacy, resulting in an 80% reduction in tooth breakdown and cavitation. These benefits are provided over the total lifespan of the patient, a previously unobtainable timescale, without bacterial resistance development, or changes to the underlying materials used and clinician workflow.
Watch Mesosil's elevator pitch and poster over at www.synapselifescience.com/competition
Click on the Mesosil Poster to see a larger view!
great poster Mesosil!
Ask the team from Mesosil a question, or make a connection by posting a comment!
Hello everyone! We're happy to talk during the event and beyond, feel free to reach out to us here,or with any of the following methods:
Join our Google Hangouts video chat - https://hangouts.google.com/call/0cMB4L0bqKXMBAInXSLlAEEE?no_rd
Set up a meeting - https://calendly.com/mesosil-info
Or email us directly - info@mesosil.com
Hope to hear from you soon!
Congratulations Mesosil on making it through the Synapse Competition!
We're all impressed by the commitment and effort that you've put in over the last few months to get to this stage.
We hope that participating in the Competition was a valuable experience for you - and remember, there are still lots of ways that Innovation Factory, the Synapse Consortium and the rest of the Hamilton ecosystem can provide support!
Hi, looks like a great solution. My question - why is Dental your first market, rather than wound care or other medical areas?
Hi Richard, good question, and there are a few reasons. First, our own domain expertise was in dentistry and dentistry in general has a low regulatory barrier to entry, so it was a natural fit. Second, the wound care space is mostly focused on short-term efficacy (under a week in most cases), while one of our material's biggest differentiator is extremely long-term efficacy (years). This makes "permanent" implanted materials (like dental work) a very attractive first use.
That being said, at the end of the day we have a disinfectant material that can stabilize and release a large amount of disinfectant. We're actually currently looking at incorporating our filler into masks and other PPE as an antiviral to kill pathogens in droplets that land on these items, and pose a transmission risk to the wearer.
It was an absolute pleasure working with Mesosil. I am really excited to see what's in store for this innovative company in the world of antibiotic alternatives!!
It was great working on this project, we're available to answer any questions and also feel free to send your questions to info@mesosil.com. Our website is https://www.mesosil.com/
Thanks to Synapse for setting up tonight event and giving us a platform to network under the current circumstances! Feel free to reach out in the future using the links above or message here, we will still be responding!